376 related articles for article (PubMed ID: 24618835)
21. Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression.
Bowers LW; Cavazos DA; Maximo IX; Brenner AJ; Hursting SD; deGraffenried LA
Breast Cancer Res; 2013; 15(4):R59. PubMed ID: 23880059
[TBL] [Abstract][Full Text] [Related]
22. Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231).
Elumalai P; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
Cell Biochem Funct; 2014 Jul; 32(5):476-84. PubMed ID: 24888707
[TBL] [Abstract][Full Text] [Related]
23. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
24. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
25. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
Park SK; Sanders BG; Kline K
Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
[TBL] [Abstract][Full Text] [Related]
26. Calycosin stimulates the osteogenic differentiation of rat calvarial osteoblasts by activating the IGF1R/PI3K/Akt signaling pathway.
Fang Y; Xue Z; Zhao L; Yang X; Yang Y; Zhou X; Feng S; Chen K
Cell Biol Int; 2019 Mar; 43(3):323-332. PubMed ID: 30632644
[TBL] [Abstract][Full Text] [Related]
27. Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.
Gaben AM; Sabbah M; Redeuilh G; Bedin M; Mester J
BMC Cancer; 2012 Jul; 12():291. PubMed ID: 22799881
[TBL] [Abstract][Full Text] [Related]
28. Role of androgen receptor on cyclic mechanical stretch-regulated proliferation of C2C12 myoblasts and its upstream signals: IGF-1-mediated PI3K/Akt and MAPKs pathways.
Ma Y; Fu S; Lu L; Wang X
Mol Cell Endocrinol; 2017 Jul; 450():83-93. PubMed ID: 28454723
[TBL] [Abstract][Full Text] [Related]
29. IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.
Kruger DT; Alexi X; Opdam M; Schuurman K; Voorwerk L; Sanders J; van der Noort V; Boven E; Zwart W; Linn SC
Int J Cancer; 2020 Apr; 146(8):2348-2359. PubMed ID: 31490549
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
Luey BC; May FE
Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy.
Davison Z; de Blacquière GE; Westley BR; May FE
Neoplasia; 2011 Jun; 13(6):504-15. PubMed ID: 21677874
[TBL] [Abstract][Full Text] [Related]
32. Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling.
Wang C; Xu CX; Bu Y; Bottum KM; Tischkau SA
Carcinogenesis; 2014 Mar; 35(3):703-13. PubMed ID: 24163404
[TBL] [Abstract][Full Text] [Related]
33. Signaling pathways activated by PACAP in MCF-7 breast cancer cells.
Zibara K; Zeidan A; Mallah K; Kassem N; Awad A; Mazurier F; Badran B; El-Zein N
Cell Signal; 2018 Oct; 50():37-47. PubMed ID: 29935235
[TBL] [Abstract][Full Text] [Related]
34. Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7.
Tian J; Duan YX; Bei CY; Chen J
Horm Metab Res; 2013 Aug; 45(8):593-8. PubMed ID: 23609007
[TBL] [Abstract][Full Text] [Related]
35. miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.
Zhang H; Zheng XD; Zeng XH; Li L; Zhou Q
Yakugaku Zasshi; 2021 Mar; 141(3):415-426. PubMed ID: 33116033
[TBL] [Abstract][Full Text] [Related]
36. Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha.
Lam L; Hu X; Aktary Z; Andrews DW; Pasdar M
Breast Cancer Res Treat; 2009 Dec; 118(3):605-21. PubMed ID: 19002577
[TBL] [Abstract][Full Text] [Related]
37. Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells.
Mendoza RA; Enriquez MI; Mejia SM; Moody EE; Thordarson G
J Endocrinol; 2011 Jan; 208(1):1-9. PubMed ID: 20974640
[TBL] [Abstract][Full Text] [Related]
38. Calycosin induces apoptosis by the regulation of ERβ/miR-17 signaling pathway in human colorectal cancer cells.
Chen J; Zhao X; Li X; Wu Y
Food Funct; 2015 Sep; 6(9):3091-7. PubMed ID: 26215320
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.
Dhar K; Banerjee S; Dhar G; Sengupta K; Banerjee SK
Cancer Res; 2007 Feb; 67(4):1520-6. PubMed ID: 17308090
[TBL] [Abstract][Full Text] [Related]
40. p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer.
Meng F; Zhang H; Liu G; Kreike B; Chen W; Sethi S; Miller FR; Wu G
Neoplasia; 2011 May; 13(5):472-82. PubMed ID: 21532888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
